Blog

One of the most frustrating realities of conventional cancer care is how much of the treatment process is built on averages. A diagnosis is matched to a standard protocol. The protocol is given to thousands of patients. Some respond. Some don't. The reasons often aren't fully understood until well into treatment.

RGCC blood testing is built around a different premise: that the most useful information about how your cancer will respond to treatment is sitting in your blood, right now.

For patients in Carlsbad and across San Diego County, RGCC testing has become a cornerstone of personalized integrative oncology at Quantum Functional Medicine. This article explains what RGCC testing is, what it measures, how it shapes treatment decisions, and what to expect if you're considering it.

What Is RGCC Testing?

RGCC stands for Research Genetic Cancer Centre — a Greek laboratory that pioneered a suite of blood-based cancer diagnostics built around the analysis of circulating tumor cells (CTCs) and cancer stem cells.

Rather than analyzing a tumor biopsy alone, RGCC testing draws a blood sample, isolates the cancer cells circulating in the bloodstream, and then runs a series of analyses on those cells. The result is a personalized profile of the patient's cancer — not as a static lump of tissue, but as a living, traveling biological entity.

For integrative oncology practitioners, that profile is a roadmap. It tells the clinician which agents — both conventional and natural — the patient's specific cancer cells appear to respond to.

What RGCC Tests Actually Measure

RGCC offers a suite of tests, each with a different purpose. The most commonly used in integrative oncology include:

Detection and Monitoring Panels

These panels look for the presence and concentration of circulating tumor cells in the bloodstream. They can be used early as a screening tool in higher-risk patients, and they are particularly valuable for ongoing monitoring during and after treatment.

Chemosensitivity Testing

This is the panel most patients ask about. Chemosensitivity testing exposes the patient's circulating tumor cells to a panel of chemotherapy agents in a lab setting and measures the response. The output: a ranked list of which agents the cancer cells appear most and least sensitive to.

Natural Substance Sensitivity Testing

Similar in design to the chemosensitivity panel, this test looks at the response of the patient's cancer cells to a wide range of natural compounds — botanicals, nutrients, and other agents commonly used in integrative oncology.

Genetic and Immune Profiling

Additional panels look at gene expression, immune phenotype, and other markers that help shape the treatment plan and predict likely response patterns.

The full suite isn't always run on every patient. The clinical team selects the panels most relevant to the patient's diagnosis, stage, and goals.

Why RGCC Testing Matters for Treatment Planning

The clearest benefit of RGCC testing is the move from standard to personalized. A few specific examples of what that looks like in practice:

• A patient with a recurrence has chemosensitivity testing run on their current circulating tumor cells. The agents that worked the first time may no longer be the highest-ranking choices — the cancer has evolved. RGCC reveals that.
• A patient considering FCBRM (fractionated chemotherapy with a bio-response modifier) has chemosensitivity testing run to identify which agents to include in the protocol. The result is a more targeted treatment design.
• A patient pursuing a natural-agent-heavy protocol uses the natural substance sensitivity panel to prioritize which compounds to focus the budget and the body's resources on.
• A patient in remission uses periodic CTC monitoring as an early-warning system — looking for changes well before a tumor would become visible on standard imaging.

In short: RGCC testing replaces guesswork with data. It doesn't guarantee any particular outcome, but it gives the clinical team a far clearer view of what to try first.

What to Expect From the Process at Our Carlsbad Clinic

Patients who pursue RGCC testing through Quantum Functional Medicine in Carlsbad typically move through a structured process:

1. Initial consultation. Your case is reviewed and a determination is made about which RGCC panels are most relevant.
2. Sample collection. A specialized blood draw is performed, with strict protocols to preserve the integrity of the circulating tumor cells.
3. Shipping to the RGCC laboratory. The sample is shipped to the lab in Greece, where the analysis is performed.
4. Results review. Once results are returned (typically several weeks), they are reviewed in detail with you. The team walks through what the panel showed, how it shapes the recommended protocol, and what questions remain.
5. Treatment design. The findings are integrated into the broader integrative cancer care plan — including FCBRM, natural agents, metabolic support, and any other relevant therapies.

The blood draw itself is straightforward — closer to a standard lab visit than to a procedure. Most patients are in and out in under an hour.

RGCC Testing as Part of a Larger Strategy

It's worth being clear about what RGCC testing is and isn't:

• It is not a diagnostic replacement for biopsy or imaging.
• It is not a cure or a treatment by itself.
• It is a powerful tool for guiding which therapies to use, and for monitoring how treatment is working over time.

Used inside a broader integrative cancer care framework — alongside imaging, conventional pathology, metabolic testing, and clinical assessment — RGCC testing helps personalize the protocol in ways that standard care typically doesn't offer.

Frequently Asked Questions About RGCC Blood Testing in Carlsbad

Is RGCC testing FDA-approved?

RGCC tests are performed by a laboratory in Greece and are not FDA-approved tests. They are used internationally as part of integrative oncology practice. Patients should discuss the role of RGCC results in their care with their full medical team.

How long does it take to get RGCC results back?

Turnaround times vary by panel but typically range from three to six weeks from the time the sample arrives at the lab in Greece.

Does RGCC testing replace a biopsy?

No. RGCC testing is a complementary tool, not a replacement for tissue biopsy or imaging. It provides a different type of information — focused on the circulating cancer cell population.

Can RGCC testing detect cancer before it shows up on imaging?

RGCC's CTC panels can identify circulating tumor cells in the bloodstream that may not be visible on standard imaging. This is one of the reasons it is sometimes used for monitoring after treatment. However, RGCC results should always be interpreted alongside other diagnostic information.

Is RGCC testing covered by insurance?

RGCC testing is generally not covered by standard insurance plans in the United States. Costs vary by panel; our team will review pricing with you before testing is ordered.

Do I need to travel to Greece?

No. The blood draw is performed at our Carlsbad clinic. The sample is then shipped to the RGCC laboratory under controlled conditions.

Who is RGCC testing best suited for?

RGCC testing is most useful for patients who are actively designing a treatment plan, evaluating a recurrence, or monitoring after treatment. It is also used as an early-screening tool in patients at elevated risk. Suitability is decided case by case during consultation.

Getting Started With RGCC Testing in Carlsbad

If you're exploring whether RGCC testing fits your situation, the first step is a consultation. Our team will review your records, walk through the panels available, and recommend which — if any — make sense for your case.

Schedule a consultation with Quantum Functional Medicine

This article is for educational purposes only and does not constitute medical advice. Cancer care decisions should be made in consultation with your full medical team. Individual results vary, and no specific outcome is promised or implied.